Omar Nadeem
@OmarNadeemMD
Multiple Myeloma Physician/Clinical Investigator | @danafarber @harvardmed #multiplemyeloma #mmsm
ID:935695664096403456
29-11-2017 02:23:25
485 Tweets
1,0K Followers
284 Following
As NY celebrates Aaron Judge’s 61st home run, the bigger NY/BOS matchup is tonight with Memorial Sloan Kettering Cancer Center and Dana-Farber going head to head discussing all the hot topics in MM and CML! Register now! cvent.me/3rnx9Y #mmsm Clifton Mo Shonali Midha, M.D. Saad Z. Usmani MD MBA FACP (he/his/him)
Incredible work by the team Memorial Sloan Kettering Cancer Center led by Eric Smith Dana-Farber & Sham Mailankody of first-in-human GPRC5D CAR-T in RRMM published in NEJM #mmsm :
⭐️ORR 71% (n=17)
⭐️67% MRD (8/12)
⭐️70% obj response in prior BCMA-exposed
nejm.org/doi/full/10.10…
Looking forward to an exciting Face-Off on September 29th when we, Memorial Sloan Kettering Cancer Center take on Dana-Farber in analyzing key datasets in the treatment of patients with CML and multiple myeloma #mmsm . Register today: cvent.me/3rnx9Y Malin Hultcrantz MD PhD Carlyn Tan
Join Omar Nadeem on August 31 for a concise and informative 30-minute webinar covering abstracts from the #IMS22 meeting on advances in chimeric antigen receptor T (CAR-T) cell therapy. Register Now! bit.ly/3pNDdKk #hematology #oncology
Mezi might be my new favorite nickname for a drug! Impressive responses with PI combinations presented by Paul Richardson. Dana-Farber Myeloma Society #mmsm #IMS2022
Excellent presentation by Romanos Sklavenitis-Pistofidis on immune cell changes in HR-SMM patients treated with Elo/Len/Dex Dana-Farber Harvard Medical School Center for Prevention of Progression of Cancer Ghobrial Lab Irene Ghobrial #IMS22
Largest collaborative study from 5 countries and 237 patients with AL amyloidosis with renal transplantation and a median f/u of 8.5 years, showing overall and renal graft survival benefit. BU AMYLOIDOSIS CENTER Andrea Havasi
nature.com/articles/s4140…
On 8/17 @ 1 PM ET, Sagar Lonial MD and Omar Nadeem at Dana-Farber Harvard Medical School and Winship Cancer Institute of Emory University discuss #multiple myeloma precursor conditions. #mmsm Register here: ow.ly/ISot50K8FFr
If you have a myeloma precursor condition or know someone who does, be sure to join our webinar on 8/17 @ 1 PM ET. Sagar Lonial MD and Omar Nadeem will review MGUS and SMM, including what these conditions are and why they’re important. #mmsm To register: ow.ly/ibOg50K7L8Y
WATCH: Experts discuss frontline therapy for transplant-eligible multiple myeloma/ the role of MRD negativity. Ajai Chari Krina Patel Cristina Gasparetto Rafael Fonseca MD 🇺🇸🏜🇲🇽 Omar Nadeem Icahn School of Medicine at Mount Sinai MD Anderson Cancer Center Duke Health Mayo Clinic Dana-Farber #mymsm ow.ly/mtbO50JUVQB
doi.org/10.1038/s41467… or as a PDF here nature.com/articles/s4146…
Our manuscript is out Gad Getz Laboratory Mark Bustoros